| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.57 | 0.0003 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0003 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |